Jubbonti Injection
Product Images NDC 61314-240

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Jubbonti (NDC 61314-240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig-1 (Fig 1)

This text provides data on the patient hip fracture incidence reported as 10% for both the placebo group (N = 3906) and the denosumab group (N = 3902). It also specifies that the study was conducted over multiple months and mentions that the N represents the number of subjects randomized.*

FDA Label Image

Image-1 (Image 01)

This appears to be a description of a medical device, most likely a syringe. It outlines different parts of the syringe including the plunger head, plunger, safety guard wings, safety guard, expiry date, viewing window, needle cap, needle, and instructions for use "Before Use" and "After Use." This information is crucial for the proper usage, handling, and disposal of the syringe.*

FDA Label Image

Image-2 (Image 02)

FDA Label Image

Image3 (Image 03)

FDA Label Image

Image4 (Image 04)

FDA Label Image

Image5 (Image 05)

FDA Label Image

Label (Image 06)

This text seems to be an instruction for dispensing medication. It mentions a 60 mg/mL dose prefilled syringe for subcutaneous use. The medication is denosumab-bbds. For further information, contact the provided phone number or visit the website.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.